Different effects of constitutive nitric oxide synthase and heme oxygenase on pulmonary or liver metastasis of colon cancer in mice

Clinical and Experimental Metastasis

Volumn 20, Issue 5, 2003, Pages 445-450

  Ishikawa, Takeshi ^a   Yoshida, Norimasa ^a   Higashihara, Hiroshi ^a   Inoue, Mamoru ^a   Uchiyama, Kazuhiko ^a   Takagi, Tomohisa ^a   Handa, Osamu ^a   Kokura, Satoshi ^a   Naito, Yuji ^a   Okanoue, Takeshi ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cancer; Carbon monoxide; Colon cancer; Heme oxygenase; Metastasis; Nitric oxide; Nitric oxide synthase

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE; HEME OXYGENASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG; ZINC DEUTEROPORPHYRIN 2,4 DIGLYCOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER MODEL; CELL COUNT; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; LIVER METASTASIS; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; QUANTITATIVE ANALYSIS; TISSUE SPECIFICITY;

ANIMALS; CARBON MONOXIDE; COLONIC NEOPLASMS; DEUTEROPORPHYRINS; HEME OXYGENASE (DECYCLIZING); LIVER; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PLATELET AGGREGATION; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0042737675     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025448403124     Document Type: Article

References (37)

1. Fidler IJ. Critical factors in the biology of human cancer metastasis. Cancer Res 1990; 50: 6130-8.
2. Nicolson G. Cancer metastasis: Tumor cells and host-organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta 1986; 948: 175-224.
3. Radinsky R. Growth factors and their receptors in metastasis. Semin Cancer Biol 1991; 2: 169-77.
4. Moncada SR, Palmer MJ, Higgs EM. Nitric oxide: Physiology, pathophysiology Pharmacol Rev 1992; 43: 109-42.
5. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-64.
6. Moncada SR. The L-arginine: Nitric oxide pathway. Acta Physiol Scand 1992; 145: 201-27.
7. Denis M. Tumor necrosis factor and granulocyte macrophage colony stimulating factor stimulate human macrophages to restrict growth of virulent mycobacterium avium and to kill a virulent M. avium: Killing effector mechanisms depend on the generation of reactive nitrogen intermediates. J Leuk Biol 1991; 49: 380-7.
8. Scott-Burden T, Schini VB, Elizondo E et al. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 1992; 71: 1088-100.
9. Radomski MW, Palmer RM, Moncada S. Characterization of the L-arginine: Nitric oxide pathway in human platelets. Br J Pharmacol 1990; 101: 325-8.
10. Forstermann U, Gorsky LD, Pollock JS et al. Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol 1990; 38: 7-13.
11. Fast DJ, Lynch RC, Leu RW. Nitric oxide production by tumor targets in response to TNF: Paradoxical correlation with susceptibility to TNF-mediated cytotoxicity without direct involvement in the cytotoxic mechanism. J Leuk Biol 1992; 52: 255-61.
12. Jenkins DC, Charles IG, Baylis SA et al. Human colorectal adenocarcinoma cells: Differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 1991; 51: 6073-8.
13. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-6.
14. Ignarro LJ, Buga GM, Wood KS et al. Endotherium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 87: 9265-9.
15. Radomski MW, Palmer RMJ, Moncada S. L-Arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193-7.
16. Kong L, Dunn GD, Keefer LK et al. Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules. Clin Exp Metastasis 1996; 14: 335-43.
17. Takahashi M, Ikeda U, Masuyama J et al. Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 1986; 8: 814-21.
18. Dong Z, Staroselsky AH, Qi X et al. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 1994; 54: 789-93.
19. Vidal MJ, Zocchi MR, Poggi A et al. Involvement of nitric oxide in tumor cell adhesion to cytokine-activated endothelial cells. J Cardiovascular Pharmacol 1992; 20: S155-9.
20. Edwards P, Cendan JC, Topping DB et al. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorgenesis and experimental lung metastasis in vivo. J Surg Res 1996; 63: 49-52.
21. Brune M, Ullrich V. Inhibition of platelet aggregation by carbon monoxide mediated by activation of guanylate cyclase. Mol Pharmacol 1987; 32: 497-504.
22. Schmidt HW. NO, CO and OH: Endogenous soluble guanylyl cyclase activating factors. FEBS Lett 1992; 307: 102-7.
23. Vedernikov YP, Graser T, Vanin AF. Similar endothelium-independent arterial relaxation by carbon monoxide and nitric oxide. Biomed Biochim Acta 1989; 48: 601-3.
24. Suematsu M, Goda N, Sano T et al. Carbon monoxide: An endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest 1995; 96: 2431-7.
25. Radomski MW, Jenkins DC, Holmes L et al. Human colorectal adenocarcinoma cells: Differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 1991; 51: 6073-8.
26. Corbett TH, Griswold DP, Robert BJ et al. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assay, with a note on carcinogen structure. Cancer Res. 1975; 35: 2434-9.
27. Suematsu M, Kashiwagi S, Sano T et al. Carbon monoxide as an endogenous modulator of hepatic vascular perfusion. Biochem Biophys Res Commun 1994; 205: 1333-7.
28. Goda N, Suzuki K, Naito M et al. Distribution of heme oxygenase isoforms in rat liver. Topographic basis for monoxide-mediated microvascular relaxation. J Clin Invest 1998; 101: 604-12.
29. Gasic GJ, Gasic TB, Galanti N et al. Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer 1973; 11: 704-13.
30. Pearlstein E, Salk PL, Yogeeswaran G et al. Correlation between spontaneous matastatic potential, platelet-aggregating activity of cell surface extract, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proc Natl Acad Sci USA 1980; 77: 4336-9.
31. Mehta P. Potential role of platelets in the pathogenesis of tumor metastasis. Blood 1984; 63: 55-63.
32. Wu QD, Wang JH, Condron C et al. Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol 2001; 280: C814-22.
33. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-5.
34. Provost P, Lam JY, Lacoste L et al. Endothelium-derived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions. Arterioscl Thromb 1994; 14: 331-5.
35. Hayashi S, Takamiya R, Yamaguchi T et al. Induction of heme oxigenase-1 attenuates oxidative stress-induced leukocyte adhesion: Roles of bilirubin generated by the enzyme. Circ Res 1999; 85: 663-71.
36. Okahara H, Yagita H, Miyake K et al. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule (VCAM-1) in tumor-necrosis-factor-alpha enhancement of experimental metastasis. Cancer Res 1994; 54: 3233-6.
37. Khatib AM, Kontogiannea M, Fallavollita L et al. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 1999; 59: 1356-61.